0001714798-18-000002.txt : 20180314 0001714798-18-000002.hdr.sgml : 20180314 20180314171839 ACCESSION NUMBER: 0001714798-18-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180314 DATE AS OF CHANGE: 20180314 EFFECTIVENESS DATE: 20180314 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prevail Therapeutics Inc. CENTRAL INDEX KEY: 0001714798 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-307751 FILM NUMBER: 18690287 BUSINESS ADDRESS: STREET 1: 430 EAST 29TH STREET, SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 BUSINESS PHONE: 917-336-9310 MAIL ADDRESS: STREET 1: 430 EAST 29TH STREET, SUITE 940 CITY: NEW YORK STATE: NY ZIP: 10016 D 1 primary_doc.xml X0708 D LIVE 0001714798 Prevail Therapeutics Inc. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY NEW YORK 10016 917-336-9310 DELAWARE None None Corporation true 2017 ASA ABELIOVICH C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY NEW YORK 10016 Executive Officer Director MONA ASHIYA C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY NEW YORK 10016 Director CARL GORDON C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY NEW YORK 10016 Director PETER THOMPSON C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940 NEW YORK NY NEW YORK 10016 Director Other Health Care Decline to Disclose 06b false 2018-03-07 false true false 0 65000059 57000049 8000010 false 15 0 0 0 false Prevail Therapeutics Inc. ASA ABELIOVICH ASA ABELIOVICH PRESIDENT 2018-03-14